Boston Birth Cohort Study
Early life exposures may lead to adverse effects on health in later life. The Boston birth Cohort study is designed to study a broad array of early life factors and their effects on maternal and child health outcomes.
- Maternal Health
- Child Health
- Pregnancy Complications
- Birth Outcome, Adverse
- Eligible Ages
- Between 0 Years and 21 Years
- Eligible Genders
- Accepts Healthy Volunteers
- Mothers who deliver singleton live births at Boston Medical Center are eligible for the study.
- pregnancies that are a result of in vitro fertilization or that involve multiple gestations, fetal chromosomal abnormalities or major birth defects.
- Study Type
- Observational [Patient Registry]
- Observational Model
- Time Perspective
- Johns Hopkins Bloomberg School of Public Health
Study ContactXiaobin Wang, MD, ScD
Any woman admitted to the Labor and Delivery floor at the Boston Medical Center (BMC) who delivers a singleton live infant and meets our case (gestational age <37 weeks or birthweight <2,500 grams) or control (full term birth with birthweight >2,500 grams) criteria will be eligible. Postnatal follow-up of enrolled mother-child pair is conducted from birth to age 21 years. The Boston Birth Cohort has high-quality biospecimen collection, and comprehensive epidemiological, clinical, and environmental exposure data via standardized questionnaire interview, measurements, and review of the electronic medical records.